Tci Wealth Advisors, Inc. Ngm Biopharmaceuticals Inc Transaction History

Tci Wealth Advisors, Inc.

7 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2022 Feb 06, 2023	BUY	$3.41 - $12.93 $3,652 - $13,848	1,071 New	1,071 $5,000
Q4 2021 Jan 24, 2022	SELL	$17.26 - $22.02 $2,416 - $3,082	-140 Closed	0 $0
Q3 2021 Oct 29, 2021	BUY	$20.15 - $26.19 $2,821 - $3,666	140 New	140 $3,000
Q4 2020 Jan 21, 2021	SELL	$16.21 - $31.44 $2,220 - $4,307	-137 Closed	0 $0
Q1 2020 Apr 14, 2020	BUY	$10.0 - $19.51 $190 - $370	19 Added 16.1%	137 $2,000
Q4 2019 Jan 27, 2020	BUY	$9.97 - $20.28 $897 - $1,825	90 Added 321.43%	118 $2,000
Q3 2019 Oct 17, 2019	BUY	$13.09 - $18.19 $366 - $509	28 New	28 $0

2.6M

300

Ticker NGM
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 80,365,904
Description
NGM Biopharmaceuticals, Inc., a biopharmaceutical company, engages in the discovery and development of novel therapeutics to treat liver and metabolic diseases, retinal diseases, and cancer. The company's product candidates include Aldafermin, an engineered analog of human hormone fibroblast growth factor 19, which is in Phase IIb clinical trial...

Get notified when there are updates to the investment portfolio of Tci Wealth Advisors, Inc., based on Form 13F filings with the SEC.

Stay updated on Tci Wealth Advisors, Inc. with notifications on news.